These studies highlight the potential for NAD+ supplementation as a therapeutic intervention and hint at the possibility for additional benefits from dual KP suppression and NAD+ supplementation in the treatment of neurodegenerative diseases. The gene discussed is NPPA; the disease is neurodegenerative disease.